The GoodRx Prescription Savings Blog

The latest updates on prescription drugs and ways to save from the GoodRx medical team

FDA Approves Mavyret for Hepatitis C

by The GoodRx Pharmacist on August 23, 2017 at 4:25 pm

Since the FDA created the Priority Review Program, aimed at fast tracking the development of drugs used to treat serious conditions, new hepatitis C medications are being approved at a faster rate.

Recently, the FDA approved Mavyret, a new combination medication for hepatitis C.

What is Mavyret prescribed for?

Mavyret is a combination medication indicated for the treatment of all major genotypes for chronic hepatitis C.

Mavyret will be available as a combination tablet in the strength of 100mg/40mg, supplied in a 4-week (monthly) dose wallet. The recommended dose is 3 tablets once daily, for 8 weeks, with food. You may need to take Mavyret for longer than 8 weeks if you have been previously treated with other medications, or have mild liver disease.

What are the most common side effects associated with Mavyret?

The most common side effects include headache and fatigue. Be sure to speak with your doctor if you experience any of these side effects for a prolonged period of time.

Is there anything unique about Mavyret?

Yes. Mavyret is the only 8-week treatment for patients with hepatitis C, without liver disease, who have not been treated before.

Mavyret will more than likely be considered a specialty medication. You can read more about specialty medications here.

How much will Mavyret cost?

Abbvie has priced Mavyret at $13,200 per month, or $26,400 per treatment course, before discounts. Although this is still expensive, Macyret is priced significantly lower than other hepatitis C treatments. For instance, popular medications Epclusa, Sovaldi and Harvoni are priced at $74,760, $84,000, and $94,500 respectively.

There is good news, though! Abbie offers a co-pay assistance program for commercially insured patients. If you are eligible, you may pay as little as $5 per co-pay using their Abbvie HCV Co-Pay Card. Visit the website here, and call 1-877-628-9738 to learn more and find out if you are eligible.

For more information on Mavyret, see the press announcement here, and visit the Mavyret website here.


Copyright ©2015 GoodRx, Inc.

This information is for informational purposes only and is not meant to be a substitute for professional medical advice, diagnosis or treatment. GoodRx is not offering advice, recommending or endorsing any specific prescription drug, pharmacy or other information on the site. GoodRx provides no warranty for any of the pricing data or other information. Please seek medical advice before starting, changing or terminating any medical treatment. Third party logos, trademarks, brand names and images contained on GoodRx.com are for demonstration purposes only and are owned by their respective rights holders, who are not affiliated with this Site.